Aphena Pharma Solutions - Maryland, LLC

Form 483 issued February 20, 2026 · Easton, Maryland

Inspection
Feb 17 – Feb 20, 2026
Observations
3
Pages
6
FEI number
1130591

In short: On February 20, 2026, FDA issued a Form 483 with 3 observations to Aphena Pharma Solutions - Maryland, LLC in Easton, Maryland (FEI 1130591) after an inspection that ran Feb 17 – Feb 20, 2026. The investigators were David A. Oluwo and Ofuje D. Daniyan. Most observations concern quality system and materials.

At a glance

2 of 3 observations on this 483 concern quality system.

Quality system2
Materials1

What FDA observed

Preview: the opening words of each observation
  1. 01

    There is a failure to thoroughly review any unexplained discrepancy and the failure of a batch…

  2. 02

    The responsibilities and procedures applicable to the quality control unit are not in writing and…

  3. 03

    Written procedures are lacking which describe in sufficient detail the receipt, testing, approval and rejection of…

The full 483

Plus the full detail behind each one, exactly as FDA wrote it.

Get the full 483

This inspection in context

Questions about this 483

What did FDA find at Aphena Pharma Solutions - Maryland, LLC?

FDA listed 3 observations on this Form 483, mostly about quality system and materials. The opening words of each observation are shown on this page.

Who inspected Aphena Pharma Solutions - Maryland, LLC?

David A. Oluwo and Ofuje D. Daniyan are named on this Form 483, for the inspection of Feb 17 – Feb 20, 2026. Each investigator has a profile showing what they cite most.

When was Aphena Pharma Solutions - Maryland, LLC inspected by FDA?

The inspection ran Feb 17 – Feb 20, 2026, and the Form 483 is dated February 20, 2026.

How do I get the full Form 483 for Aphena Pharma Solutions - Maryland, LLC?

Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.

$99Get it free